Generic drug manufacturers in our country point out that the introduction of treatments on the compensation list occurs with delays of up to two years. In parallel, while production costs are increasing, the prices of generic drugs have been constantly decreasing in the last decade, which risks leading to the withdrawal of essential therapies from the market. • Increasing costs, decreasing prices "In the last 10 years, while the costs of raw materials and industrial goods have increased by 30-